BioNTech SE (BNTX) Research & Development (2018 - 2025)

BioNTech SE has disclosed Research & Development across 8 years of filings, most recently posting -$588.3 million for Q4 2025.

• Research & Development for Q4 2025 came in at -$588.3 million, up 10.01% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.4 billion (up 2.51% YoY), and the FY2025 annual result was -$2.4 billion, up 1.27% from the prior year.
• Research & Development came in at -$588.3 million for Q4 2025 at BioNTech SE, up from -$660.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of -$242.2 million in Q2 2021 to a low of -$660.3 million in Q3 2025.
• The 5-year median for Research & Development is -$531.1 million (2022), against an average of -$473.9 million.
• Across the five-year window, Research & Development sank 101360660.56% in 2021 and advanced 10.01% in 2025, its largest moves.
• BioNTech SE's Research & Development stood at -$310.6 million in 2021, then plunged by 67.46% to -$520.1 million in 2022, then dropped by 19.53% to -$621.7 million in 2023, then fell by 5.16% to -$653.8 million in 2024, then advanced by 10.01% to -$588.3 million in 2025.
• The last three Research & Development figures came in at -$588.3 million (Q4 2025), -$660.3 million (Q3 2025), and -$576.3 million (Q2 2025), per Business Quant data.